Guangdong basic medicine supplement "great leap forward" traditional Chinese medicine exclusive variety continues to be favored

Guangdong Provincial Department of Health yesterday (4) released the local basic medicine supplement catalogue, which is the second province to release the local basic medicine supplement catalogue after Qinghai The capacity of 278 varieties in Guangdong was expanded this time, and the supplement catalogue of base drugs in the previous version continued to be implemented, with the degree of looseness far greater than expected According to the document, 147 varieties of chemicals and biological products and 131 kinds of Chinese patent medicines were added in this Guangdong supplement In the previous edition of the basic drug supplement, 244 drugs were added in Guangdong At that time, Guangdong said in an interview that the drugs in the national basic drug catalog were not enough for basic level use On March 15, the national new version of the base drug catalog was released, expanding from 307 in the first version to 520 It is generally expected that the central government will start to tighten its attitude towards provincial supplements on the premise that the new version of the base drug itself has been expanded, and the situation like the large number of provincial supplements of the first version of the base drug will not reappear The central "look back" plan also clearly points out that there are more varieties to be supplemented However, before that, a person from the medical administration department of the Department of health of Zhejiang Province disclosed to the big wisdom news agency that "Zhejiang and other major drug using provinces have a large demand for drugs, and the new version of basic drugs is not enough." On July 1, Qinghai took the lead in releasing the first local base drug supplement catalogue, adding 200 varieties, which was looser than expected and attracted the attention of the industry This time, Guangdong also followed Qinghai's lead, and the capacity of supplementary varieties increased dramatically The exclusive varieties of traditional Chinese medicine continue to be favored According to statistics, Guangdong has added more than 100 exclusive varieties of new Chinese patent medicine, and the only few non exclusive manufacturers are mostly within 20, which are also products with strong price discourse The catalogue shows that the new exclusive varieties and their listed companies include: Baimai ointment of Qizheng Tibetan medicine, Biyuanshu oral liquid (capsule) of Huashen group, Danhong Huatan oral liquid of Guangzhou Pharmaceutical, Gongxuening Capsule of Yunnan Baiyao, zhennaoning capsule of Tonghua Dongbao, Tianshu tablet of Kangyuan pharmaceutical, Dazhu Hongjingtian price capsule, Reduning Injection and Tongsaimai Tablet, ginseng of China Resources Sanjiu Injection, Guanxinkang tablet of taiantang, Zhuyu Tongmai capsule of Harbin Pharmaceutical Co., Ltd., Xinnaoshutong Capsule and linanxin capsule of Aodong, Jilin, Maiping tablet, Qishen Yiqi dropping pill and Chuanxinlian price lactone dropping pill (capsule), YinQin capsule of Kunming Pharmaceutical, Wufu Huadu tablet of Yabao pharmaceutical, Tanreqing injection of Shanghai Kaibao, blood of HongRi pharmaceutical Bijing injection, Jinlida granule of Yiling pharmaceutical, Wuling capsule of zoelli pharmaceutical, Shenqi Schisandra price tablet (granule, capsule) and musk Tongxin dropping pill of Kangenbei.